SF-3-030
SF-3-030 is a potent, selective and non-ATP competitive ERK1/2 inhibitor. SF-3-030 selectively induces apoptosis in melanoma cells containing mutated BRaf and constitutively active ERK1/2 signalling. SF-3-030 mitigates multiple features of asthma in a murine model of asthma. SF-3-030 can be used for the research of asthma and melanomasup.
For research use only. We do not sell to patients.
- CAS No.: 1883721-73-0
- Formula: C14H12O5S2
- Molecular Weight:324.37
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
|
ERK1 |
ERK2 |
In Vitro
SF-3-030 (2.5-60 μM; 30 min) selectively inhibits ERK2-mediated phosphorylation of the F-site-dependent Thr325 residue on c-Fos in vitro, with no effect on D-domain-containing substrates (RSK1) or p38α-mediated ATF2 phosphorylation[2].
SF-3-030 (1-100 μM; 20 min-5 h) inhibits AP-1 and SRE promoter activity in EGF/PMA-stimulated HeLa/HEK293 cells and suppresses basal AP-1 activity in A375 melanoma cells, showing greater potency against PMA-induced responses than against EGF-induced activity[2].
SF-3-030 (5-100 μM; 30 min-1 h) selectively inhibits EGF/PMA (HY-18739)-induced expression of F-site-containing IEGs (c-Fos, Fra1, FosB, FosB2, c-Myc) in HeLa and A375 cells, with minimal effect on non-F-site IEGs (c-Jun, Egr1)[2].
SF-3-030 (1-100 μM; 24 h) selectively inhibits proliferation and induces apoptosis in melanoma cells (A375, RPMI7951) with constitutive ERK1/2 activity, with GI50 values of 7.1 and 4.6 μM, respectively, while showing selectivity over Jurkat cells with a GI50 > 50 μM)[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HeLa cells
-
Concentration:5, 10, 20, 35, 40, 70, 100
-
Incubation Time:30 min pretreatment
-
Result:Inhibited induction of c-Fos, FosB, FosB2, Fra1, and c-Myc in a dose-dependent manner in EGF-stimulated HeLa cells.
Showed less effect on c-Jun and Egr1 and inhibited c-Fos phosphorylation at Ser32 but not Ser374 in EGF-stimulated HeLa cells.
Inhibited c-Fos phosphorylation at Thr232 and Ser32 but not Ser374 and reduced FosB, FosB2, Fra1, and c-Myc expression
in PMA-stimulated HeLa cells.
-
Cell Line:A375 melanoma cells
-
Concentration:5, 25, 35, 50 μM
-
Incubation Time:1 h
-
Result:Inhibited basal expression of c-Fos, FosB, FosB2, Fra1, and c-Myc but not Egr1.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Balb/c mice (8-10-week-old) challenged with HDM[1]
-
Dosage:10 mg/kg
-
Administration:i.n.; 30 min before each HDM challenge; 5 days a week for 3 weeks
-
Result:Significantly attenuated HDM-induced airway inflammation.
Inhibited induction of airway remodeling (AR) by
repeated allergen challenge.
Inhibited the development of HDM-induced airway inflammation hyperresponsiveness (AHR).
Modulated gene expression profile in lung.
Modulated profile of proteins involved in multiple pathways in the lung.
Chemical Information
-
CAS No. 1883721-73-0
-
Molecular Weight 324.37
-
Formula C14H12O5S2
-
SMILES
O=S(=O)(OC1C=CS(=O)(=O)C1)C=2C=CC=3C=CC=CC3C2
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
Purity & Documentation
References
[1]. Shah SD, et al. Targeted Inhibition of Select Extracellular Signal-regulated Kinases 1 and 2 Functions Mitigates Pathological Features of Asthma in Mice. Am J Respir Cell Mol Biol. 2023 Jan;68(1):23-38. [Content Brief]
[2]. Samadani R, et al. Small-molecule inhibitors of ERK-mediated immediate early gene expression and proliferation of melanoma cells expressing mutated BRaf. Biochem J. 2015;467(3):425-438. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- SF-3-030
- 1883721-73-0
- ERK
- Apoptosis
- c-Myc
- ERK1/2
- Ki-67
- house dust mite-induced asthma
- A375 melanoma cells
- p38α
- RSK1
- HDM
- melanoma cells
- ATF2
- F-site
- BAL
- HeLa/HEK293 cells
- murine model
- IgE
- c-Jun
- FosB2
- Balb/c mice
- cyclin D1
- mutated BRaf
- Fra1
- SRE
- AP-1 transcription factor complex
- Egr1
- ERK1/2 substrate-docking domains
- FosB
- DEF motif
- c-Fos
- RPMI7951
- Inhibitor
- inhibitor
- inhibit